Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 17.
doi: 10.1002/ptr.6669. Online ahead of print.

Ursolic Acid Promotes Apoptosis, Autophagy, and Chemosensitivity in Gemcitabine-Resistant Human Pancreatic Cancer Cells

Affiliations

Ursolic Acid Promotes Apoptosis, Autophagy, and Chemosensitivity in Gemcitabine-Resistant Human Pancreatic Cancer Cells

Ji-Hua Lin et al. Phytother Res. .

Abstract

Gemcitabine (GEM) resistance in pancreatic adenocarcinoma mediated by the receptor for advanced glycation end products (RAGE) has been demonstrated. Therefore, investigating the safety and the potential of new auxiliary methods for pancreatic cancer treatment is urgent. Ursolic acid (UA), a natural pentacyclic triterpenoid found in apple peels, rosemary, and thyme, has been reported to have anticancer capacity. This study aimed to reveal the underlying mechanisms of UA in cell death and drug enhancement, especially in GEM-resistant pancreatic cancer cells. First, GEM-resistant cells (MIA Paca-2GEMR cells) were established by incrementally increasing GEM culture concentrations. UA treatment reduced cell viability through cell cycle arrest and endoplasmic reticulum (ER) stress, resulting in apoptosis and autophagy in a dose-dependent manner in MIA Paca-2 and MIA Paca-2GEMR cells. High RAGE expression in MIA Paca-2GEMR cells was suppressed by UA treatment. Interestingly, knocking down RAGE expression showed similar UA-induced effects in both cell lines. Remarkably, UA had a drug-enhancing effect by decreasing cell viability and increasing cell cytotoxicity when combined with GEM treatment. In conclusions, UA triggered ER stress, subsequently regulating apoptosis- and autophagy-related pathways and increasing GEM chemosensitivity in pancreatic cancer cells by inhibiting the expression of RAGE.

Keywords: RAGE; apoptosis; autophagy; gemcitabine resistance; pancreatic cancer; ursolic acid.

Similar articles

See all similar articles

References

REFERENCES

    1. Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernandez, T. Y., Cianciosi, D., Reboredo-Rodriguez, P., … Battino, M. (2018). Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances, 38, 1-38. https://doi.org/10.1016/j.biotechadv.2018.11.011
    1. B'Chir, W., Maurin, A. C., Carraro, V., Averous, J., Jousse, C., Muranishi, Y., … Bruhat, A. (2013). The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Research, 41(16), 7683-7699. https://doi.org/10.1093/nar/gkt563
    1. Binenbaum, Y., Na'ara, S., & Gil, Z. (2015). Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug Resistance Updates, 23, 55-68. https://doi.org/10.1016/j.drup.2015.10.002
    1. Bourougaa, K., Naski, N., Boularan, C., Mlynarczyk, C., Candeias, M. M., Marullo, S., & Fahraeus, R. (2010). Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Molecular Cell, 38(1), 78-88. https://doi.org/10.1016/j.molcel.2010.01.041
    1. Boyce, M., Bryant, K. F., Jousse, C., Long, K., Harding, H. P., Scheuner, D., … Yuan, J. (2005). A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science, 307(5711), 935-939. https://doi.org/10.1126/science.1101902

LinkOut - more resources

Feedback